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Abstract
Introduction: Transpulmonary thermodilution is used to measure cardiac output (CO), global end-diastolic volume
(GEDV) and extravascular lung water (EVLW). A system has been introduced (VolumeView/EV1000™ system,
Edwards Lifesciences, Irvine CA, USA) that employs a novel algorithm for the mathematical analysis of the
thermodilution curve. Our aim was to evaluate the agreement of this method with the established PiCCO™
method (Pulsion Medical Systems SE, Munich, Germany, clinicaltrials.gov identifier: NCT01405040)
Methods: Seventy-two critically ill patients with clinical indication for advanced hemodynamic monitoring were
included in this prospective, multicenter, observational study. During a 72-hour observation period, 443 sets of
thermodilution measurements were performed with the new system. These measurements were electronically recorded,
converted into an analog resistance signal and then re-analyzed by a PiCCO2™ device (Pulsion Medical Systems SE).
Results: For CO, GEDV, and EVLW, the systems showed a high correlation (r2 = 0.981, 0.926 and 0.971, respectively),
minimal bias (0.2 L/minute, 29.4 ml and 36.8 ml), and a low percentage error (9.7%, 11.5% and 12.2%). Changes in CO,
GEDV and EVLW were tracked with a high concordance between the two systems, with a traditional concordance for
CO, GEDV, and EVLW of 98.5%, 95.1%, and 97.7% and a polar plot concordance of 100%, 99.8% and 99.8% for CO, GEDV,
and EVLW, respectively. Radial limits of agreement for CO, GEDV and EVLW were 0.31 ml/minute, 81 ml and 40 ml,
respectively. The precision of GEDV measurements was significantly better using the VolumeView™ algorithm
compared to the PiCCO™ algorithm (0.033 (0.03) versus 0.040 (0.03; median (interquartile range), P = 0.000049).
Conclusions: For CO, GEDV, and EVLW, the agreement of both the individual measurements as well as
measurements of change showed the interchangeability of the two methods. For the VolumeView method, the
higher precision may indicate a more robust GEDV algorithm.
Trial registration: clinicaltrials.gov NCT01405040.
Keywords: cardiac output, concordance, extravascular lung water, global end diastolic volume, monitoring, trans-
pulmonary thermodilution
Introduction
Measurement of cardiac output (CO) and other para-
meters that guide cardiovascular therapy is paramount
for the hemodynamic management of critically ill
patients. Pulmonary thermodilution and pulmonary
artery occlusion pressure have been the mainstay of
advanced hemodynamic monitoring for decades. How-
ever, studies revealed conflicting results regarding the
use of the pulmonary artery catheter (PAC) in order to
improve the morbidity and mortality of critically ill
patients [1-3] and as a result, PAC use is decreasing [4].
Meanwhile, less invasive techniques for CO measure-
ment have emerged, such as transpulmonary thermodi-
lution (TPTD), which has been validated in a variety of
clinical settings (a review of all available validation stu-
dies is provided in [5]). In addition to CO
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measurements, TPTD provides volumetric hemody-
namic parameters, that is, global end-diastolic volume
(GEDV) and extravascular lung water (EVLW). GEDV
has been shown to be a more reliable parameter of
intravascular volume status when compared with the
standard pressure preload parameters [6-8]. EVLW is a
sensitive marker of pulmonary edema and a valuable
prognostic parameter [9,10]. TPTD can be reliably per-
formed at bedside [11] and has been successfully imple-
mented in algorithms for goal directed hemodynamic
therapy [12].
Recently, a new TPTD system has been developed and
introduced into clinical practice. It consists of a specific
thermistor-tipped arterial catheter, the VolumeView™
catheter and EV 1000™ monitoring platform (Edwards
Lifesciences, Irvine, CA, USA) and employs a novel
algorithm for the mathematical analysis of the thermodi-
lution curve (details are described in the methods sec-
tion). So far, the system has been validated in an animal
model only [13]. That study revealed good agreement
with measurements performed by the PiCCO™ system
(Pulsion Medical Systems SE, Munich, Germany) that
has been the only commercially available device based
on TPTD.
The aim of the present multi-center clinical study was
to assess the agreement of the new EV 1000™ system
with the PiCCO™ system in a clinical setting of a
mixed ICU population.
Materials and methods
This prospective observational study was conducted in
four hospital centers in Germany and Switzerland
(Aachen, Bonn, Geneva, and Zurich). Approval was
obtained from local institutional review boards at all
participating institutions (Ethik-Kommission an der
Medizinischen Fakultät der Rheinisch-Westfälischen
Technischen Hochschule Aachen, Aachen, Germany;
Ethikkommission an der Medizinischen Fakultät der
Rheinischen Friedrich-Wilhelms-Universität Bonn,
Bonn, Germany; Commission Centrale d’Ethique de la
recherche sur l’être humain, Hôpitaux Universitaires de
Genève, Genève, Switzerland; Ethikkommission der bei-
den Stadtspitäler Triemli und Waid, Kantonale Ethik-
kommission des Kantons Zürich, Zürich, Switzerland).
The trial is registered at a public registry (clinicaltrials.
gov identifier: NCT01405040). All patients or their legal
representatives gave written informed consent. We
enrolled patients who had been admitted to an intensive
care unit and required advanced hemodynamic monitor-
ing by TPTD according to the treating clinician after
the patients, or their legal representatives, gave written
informed consent. Patients younger than 18 years old
were not eligible for the study; neither were patients
with a body weight less than 40 kg, according to the
manufacturer’s directions for use. Other exclusion cri-
teria were significant aortic regurgitation in the patient’s
history, treatment with an intra-aortic balloon pump,
participation in an investigational drug or device study
interfering with the endpoints of this study and a
known or potential pregnancy. During a 72-hour obser-
vation period, TPTD measurements were performed
with the VolumeView™/EV1000™ system as clinically
indicated and data were electronically recorded and
then reanalyzed offline by a PiCCO2™ System (Pulsion
Medical Systems SE, Munich, Germany, software Ver-
sion 8.0.0.6). All patients were treated at the discretion
of the ICU staff in charge; there was no specific protocol
for any intervention.
Transpulmonary thermodilution measurements
A VolumeView™ catheter (Edwards Lifesciences) was
inserted into the left or right femoral artery and con-
nected to the EV1000™ monitoring system (Edwards
Lifesciences, software version 1.0). Thermodilution
measurements were performed in sets of at least three
consecutive injections of 20 ml cold saline, randomly
distributed over the respiratory cycle. As required by
the EV1000 monitor’s software, individual boluses of
each set had to be manually validated by the attending
physician before they were included in the set. By pro-
tocol, bolus sets that contained a bolus that differed by
more than 15% from the mean within the set were
considered faulty and excluded from the analysis. Also,
boluses for which either system ’s internal artifact
recognition algorithm reported an error were not
included. All hemodynamic data were electronically
recorded at 500 Hz internally on the EV1000™ system
and downloaded for analysis. Blood temperature and
injectate temperature data were converted into an ana-
log output signal by LabView software (National
Instruments, Austin, TX, USA) and a multichannel
input/output module (NI 9263, National Instruments).
That analog signal was then transformed into a resis-
tance signal, which can be read as blood and injectate
temperature by a PiCCO2™ System (Pulsion Medical).
This set-up was validated for the relevant range of
blood and injectate temperatures by comparison of
input temperatures with the temperatures read and
stored by the PiCCO2™ device.
Algorithms for CO, GEDV and EVLW assessment
Both the PiCCO™ and the VolumeView™/EV1000™
system use the Stewart-Hamilton-equation [14] to calcu-
late the thermodilution derived cardiac output (COTD):
COTD =
Vi · (Tblood − Tinjectate) · k∫
Tblood · dt (1)
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Vi is the volume of the injectate, Tblood and Tinjectate
are blood and injectate temperatures, whereas k is a
constant proportional to the specific heat and weight of
the blood and the injectate, and t is the time from injec-
tion of the bolus.
The systems use different algorithms to assess GEDV
(Figure 1): The algorithm implemented in the
PiCCO2™ System applies mean transit time (Mtt) and
downslope time (Dst) according to the Newman para-
digm [15]:
GEDVPiCCO = CO · (Mtt − Dst) (2)
The VolumeView™/EV1000™ system employs a
newly developed algorithm requiring the determination
of the maximum up-slope (S1) and down-slope (S2) of
the thermodilution curve, and a proprietary function (f,
Figure 1):
GEDVVolumeView = CO ·Mtt · f (S1
/
S2) (3)
The algorithms for EVLW assessment are equivalent
for both systems. However, they rely on GEDV that is
calculated in different ways according to formulas 2 and
3:
EVLWPiCCO = CO ·Dst − (0.25 · GEDVPiCCO) (4)
EVLWVolumeView = CO ·Dst − (0.25 · GEDVVolumeView) (5)
Of note, formula (4) is equivalent to the typical EVLW
algorithm (11) but has been mathematically transformed
to facilitate comparison of the algorithms; details of that
conversion are shown in Additional file 1.
Statistical analysis
All thermodilution data were imported into an Excel™
spreadsheet (Microsoft, Redmond, WA, USA) that was
used to calculate bias, limits of agreement, concor-
dance and polar coordinates. All other statistical ana-
lyses were performed using PASW Statistics 18 (IBM,
Armonk, NY, USA). Normal distribution of the data
was tested using the Kolomogorov Smirnov test. A P <
0.05 was considered statistically significant. Normally
distributed data are presented as mean ± standard
deviation (SD), otherwise as median (interquartile
range). The interquartile range is calculated as the dif-
ference between the third and the first quartile. Bias
and limits of agreement were assessed as proposed by
Bland and Altman [16] with the difference between the
parameters measured by the two systems plotted
against their mean. Bias refers to the mean difference
and limits of agreement to the 95% confidence interval
of the difference with correction for repeated measure-
ments [17]. The percentage error is the relation of two
standard deviations of the difference to the mean of
both devices. To assume interchangeability, we adopted
the 30% threshold proposed by Critchley and Critchley
[18]. Paired measurements, which are two consecutive
measurements using the same method, permit the
quantification of the change within the measured para-
meter, for example, ΔCO. The difference expressed as
a percentage of the mean is termed percentage change,
Figure 1 Mathematical analysis of the thermodilution curve.
Panel a) Both algorithms rely on mean transit time (Mtt), the time
required for half of the indicator to pass the thermistor in the
femoral artery. Mtt divides the area under the curve (AUC) into two
areas of the same size (AUC1 and AUC2). Panel b) Downslope time
(Dst) is part of the PiCCO™ GEDV algorithm. It is the time of the
temperature decay between two set points in the thermodilution
curve, for example, 80% to 40%. Theoretically, the decay is mono-
exponential, so it can be measured at any time point after the peak
and be adjusted by a constant factor. Panel c) The VolumeView™
algorithm relies on maximum up-slope (S1) and maximum down-
slope (S2) of the dilution curve. This approach may be less sensitive
to early recirculation and thermal noise.
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concordance is the agreement of the direction of the
change obtained from paired measurements by the two
methods, expressed as the percentage of the total
number of data points. Data with small changes are
excluded from the analysis (’exclusion zone’) because
without significant change, data reflect only random
effects and not actual change. We used an exclusion
zone of 10%, which is smaller than recently suggested
[19], in order to use a larger proportion of the data.
Sufficient concordance to assume interchangeability
was set to 95%, following the most conservative
threshold proposed by Critchley et al. [19]. In addition,
percentage changes were plotted in a polar diagram
using the transformation described by Critchley et al.
[20]. Briefly, percentage changes were converted into
polar coordinates (angle and radius) that represent
agreement as θ, the angle to line of identity. The line
of identity, indicating equal changes obtained by the
two systems, is rotated clockwise by 45 degrees in











+ k) · 180◦/π ifpicco = 0
(6)
k is a constant used to correctly rotate radians by 45
degrees for data from different quadrants of the plot.
When the percentage change of the test method is posi-
tive, the constant is -0.79, for a negative change 2.36.
The case differentiation was introduced to avoid a divi-
sion by zero. The distance of the polar coordinates from
the centre represents the mean percentage change cal-
culated by the two algorithms.
Concordance was calculated as the percentage of data
within ± 10% ‘tram line’, a criterion chosen in analogy





Again, sufficient concordance to assume interchange-
ability was set to 95%, following the most conservative
threshold proposed by Critchley et al. [18]. Radial limits
of agreement (RLOA) are the 95% confidence interval of
the θ of all data points outside a central exclusion zone.
We chose a 10% exclusion zone in analogy to the tradi-
tional concordance. Mean θ was calculated after conver-
sion of all angles within the left quadrants to the
respective right quadrants, RLOA are mean θ ± 1.96 SD.
For interchangeability, the threshold was set to a mean
angle smaller than ± 5° and RLOA smaller than ± 30,
according to [18]. The coefficient of error (CE) of mea-
surements using the GEDV and EVLW algorithms was







SDGEDV is the SD within each set, meanGEDV is the
mean and n the number of the repeated measurements.
Precision refers to two times CE [21], thus a lower CE
indicates higher precision. EVLW measurements were
analyzed accordingly. The CE was not analyzed for CO,
as both algorithms are identical.
Results
Between March and December 2010, 72 patients were
entered into the study. Their biometric and demo-
graphic data, as well as the reasons for admission to an
ICU are presented in Table 1. During the observation
period, the patients were mostly on assisted mechanical
ventilation (62% of all scheduled visits) or breathing
spontaneously (28%). On 9% of all scheduled visits they
were on controlled mechanical ventilation. Median posi-
tive end-expiratory pressure was 6 cm H2O (5), median
tidal volume of intubated patients was 500 (168) ml.
Median of the patients’ mean arterial pressure was 77
(15) mmHg. Vasopressors (noradrenaline, adrenaline,
vasopressin) were administered during 76%, inotropes
(dobutamine, adrenaline, milrinone, levosimendan) were
administered during 33%, and nitroglycerine during 8%
of all measurements. Four hundred and forty-three
paired bolus sets with a median injectate temperature of
9 (3) °C were analyzed by both systems, allowing 370
paired change measurements. The median number of
sets per patient was 10 (5). In one patient, only one sin-
gle bolus set was recorded, precluding trend assessment.
The observed range of CO, GEDV and EVLW values is
displayed in Table 2.
The agreement of the two systems was high, exceed-
ing all prerequisites to assume interchangeability for the
measurement of CO, GEDV and EVLW. Regression
Table 1 Demographic details and reason for ICU
admission for all 72 patients.
mean
age (years) 66 ± 12
gender (m/f) 51/21
height (cm) 172 ± 8
weight (kg) 82 ± 20
reason for ICU Admission Number
post cardiac surgery 40
other (for example, respiratory failure, intracranial bleeding) 18
sepsis 7
post non cardiac surgery 4
ARDS 3
Data presented as absolute numbers or mean ± standard deviation. ARDS,
acute respiratory distress syndrome; m/f, male/female.
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analysis and Bland Altman plots of CO, GEDV and
EVLW are depicted in Figures 2, 3, and 4a and 4b; cor-
responding data are presented in Table 3. The assess-
ment of trending capability also demonstrated the
interchangeability of the two systems. Four quadrant-
and polar-plots are shown in Figures 2, 3 and 4c and
4d: the data are presented in Table 4. The precision of
the novel VolumeView™/EV1000™ algorithm was sig-
nificantly higher than that of the PiCCO algorithm for
the calculation of GEDV (CE = 0.17 (0.02) versus 0.21
(0.02), P = 0.000039). Precision did not differ between
the algorithms for the calculation of EVLW (0.22 (0.02)
versus. 0.24 (0.02), P = 0.27 for the VolumeView™/
EV1000™ and the PiCCO algorithms, respectively).
Discussion
This prospective, multi-center clinical study demon-
strates that CO, GEDV and EVLW calculated by the
newly introduced VolumeView/EV1000™ system are
interchangeable with CO, GEDV and EVLW obtained
using the PiCCO algorithms over a wide range of values
and in various clinical situations, including low cardiac
output syndrome, hyperdynamic state, hypo- and hyper-
volemia, and severe pulmonary edema. Interchangeabil-
ity was demonstrated both for the absolute measures
with a percentage error well below 30% and for the
detection of trends, with concordance in the four quad-
rant plot higher than 95%. Using the polar plot method,
interchangeability was demonstrated both with polar
plot concordance higher than 95% and RLOA smaller
than ± 30°.
For calculation of CO, both methods employ the
Stewart-Hamilton equation. Therefore, the close agree-
ment of CO assessed by the two methods was not a sur-
prise. It was substantially better than any premise
postulated for interchangeability and superior to the
agreement reported for other studies comparing CO
monitoring systems [18]. Only minimal bias, very low
percentage error and accurate trending capability were
observed. Regression analysis showed good linearity over
the entire data range. The residual disagreement can be
interpreted as a result of minor methodological differ-
ences in the calculation of the area under the curve,
which is part of the denominator in formula 1. These
differences include, for example, how the thermodilution
curve is truncated and how a recirculation-free curve is
extrapolated.
For GEDV, different mathematical algorithms are
used. The PiCCO2™ system employs a time constant
derived from the down-slope of the thermodilution
curve. The VolumeView™/EV1000 system, in contrast,
uses both the up-slope and the down-slope of the ther-
modilution curve. Therefore, more information of the
curve shape is taken into account so that, supposedly,
the algorithm is less sensitive to recirculation and ther-
mal noise. This assumption is supported by a signifi-
cantly higher precision of that algorithm. For EVLW,
interchangeability was also clearly demonstrated. Agree-
ment was not as good as for CO measurements,
although algorithms appear to be identical in both sys-
tems (formulas 4 and 5, Additional file 1). However, the
algorithms use a differently calculated GEDV, which
explains the slightly lower agreement. In contrast to
GEDV measurements, higher precision of the Volume-
View algorithm could not be demonstrated for EVLW.
This may be due to the fact that identically calculated
CO and Dst are part of the algorithms and outweigh dif-
ferences in GEDV precision. The results of the present
study show that the systems can be used interchange-
ably in various clinical situations and over a wide range
of clinically relevant conditions, such as low or high car-
diac output, hypo- and hyper-volemia and presence or
absence of pulmonary edema. These results thus con-
firm the data from a recent animal validation [13], in
which both systems, the PiCCO2, and the EV1000, were
used simultaneously in a porcine model. In that study,
the authors found a comparable bias and precision for
CO (bias: 0.2 ± 0.3 L/minute, precision error 7%),
GEDV (-11 L ± 80 ml, 14%), and EVLW (-5 ± 72 ml,
15%).
Volumetric preload indicators, such as GEDV, have
been shown to be reliable indicators of cardiac preload
[6,10,22-25] and have been successfully implemented
into therapeutic strategies that may improve outcome
[12]. EVLW, measured by single indicator dilution, is a
reliable measure of pulmonary edema that has been vali-
dated against postmortem gravimetric measurement in
animals [25], computer tomographic lung density mea-
surements and double dye dilution [26], and, recently in
a human autopsy study [27]. It is very sensitive even in
small increases of pulmonary fluid content [9] and has
been shown to be superior to other bedside measures of
pulmonary edema [28]. Additionally, it is more specific,
because only pulmonary edema and not pleural effu-
sions are assessed. It can be used as an important diag-
nostic tool for detection and surveillance of acute lung
injury [29] and as a prognostic parameter [10]. As with
Table 2 Hemodynamic parameters of all 72 patients.
PiCCO™ VolumeView™
median IQR min max median IQR min max
CO (ml/minute) 6.0 2.6 1.8 15.8 6.2 2.6 2.2 15.3
GEDV (ml) 1,,337 405 712 2,433 1,379 405 741 2,427
EVLW (ml) 566 257 265 2,132 589 246 313 2,015
CO, cardiac output; EVLW, extravascular lung water; GEDV. global end-diastolic
volume; IQR, interquartile range; max, maximum value; min, minimum value.
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Figure 2 Comparison of cardiac output measurements. Panel a) Correlation between measurements of cardiac output (CO) with the
VolumeView™/EV1000™ system and reanalysis with the PiCCO2™ system. Panel b) Bland Altman Plot, with the difference between the values
derived from the two algorithms plotted against their mean. The solid line represents bias, the two dashed lines the upper and lower limit of
agreement. Panel c) Concordance plot of percentage change. Data points within the 10% exclusion zone are grayed out. Panel d) Polar plot
with distance from the center as mean change and θ, the angle with the horizontal axis, as agreement. The dashed tram line intersects the 90°
axis at ± 10% and marks the limit of acceptable concordance. The dotted lines mark the radial limits of agreement.
Kiefer et al. Critical Care 2012, 16:R98
http://ccforum.com/content/16/3/R98
Page 6 of 11
Figure 3 Comparison of global end-diastolic volume measurements. Panel a) Correlation between global end-diastolic volume (GEDV)
computed with the PiCCO™ and the VolumeView™ algorithm. Panel b) Bland Altman Plot, with the difference between the values derived
from the two algorithms plotted against their mean. The solid line represents bias, the two dashed lines the upper and lower limit of
agreement. Panel c) Concordance plot of percentage change. Data points within the 10% exclusion zone are grayed out. Panel d) Polar plot
with distance from the center as mean change and θ, the angle with the horizontal axis, as agreement. The dashed tram line intersects the 90°
axis at ± 10% and marks the limit of acceptable concordance. The dotted lines mark the radial limits of agreement.
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Figure 4 Comparison of extravascular lung water measurements. Panel a) Correlation between extravascular lung water computed with the
PiCCO™ and the VolumeView™ algorithm. Panel b) Bland Altman Plot, with the difference between the values derived from the two algorithms
plotted against their mean. The solid line represents bias, the two dashed lines upper and lower limit of agreement. Panel c) Concordance plot
of percentage change. Data points within the 10% exclusion zone are grayed out. Panel d) Polar plot with distance from the center as mean
change and θ, the angle with the horizontal axis, as agreement. The dashed tram line intersects the 90° axis at ± 10% and marks the limit of
acceptable concordance. The dotted lines mark the radial limits of agreement.
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GEDV, EVLW has been successfully implemented into
therapeutic algorithms [30].
A major limitation of the presented data is the lack of
a third technique as a reference. In the present study,
interchangeability of the two algorithms could be
demonstrated within the limits that have been proposed
for such analysis. Only comparisons with a true gold
standard would allow individual testing of each algo-
rithm. However, the use of a gold standard, for example,
an epi-aortic flow probe [31], is not feasible at bedside
in an ICU population. Moreover, an epi-aortic flow
probe is only able to determine cardiac output; there is
no gold standard for GEDV or EVLW. Another impor-
tant limitation of the present study is that hemodynamic
measurements were not performed simultaneously by
the two devices with two thermistor-tipped femoral
artery catheters. Consequently, it is not possible to com-
pare all different system parts (for example, thermistor
for blood and injectate temperature), as only Volume-
View™/EV1000™ hardware was used to obtain raw
hemodynamic data and the PiCCO2™ calculated CO,
GEDV and EVLW from these data. The simulation
approach was used to avoid an additional arterial punc-
ture, indwelling catheter, and double measurements.
Other researchers have employed comparable strategies,
for example, for the comparison of pulse contour algo-
rithms [31,32]. Our data are in line with that of an ani-
mal study using VolumeView™ and PiCCO™ catheters
simultaneously [13], suggesting that no significant bias
was introduced. However, one has to be careful with the
interpretation, as the generally accepted threshold for
interchangeability of a performance error below 30%
[18] relies on the assumption of independent variances
of the two methods. With the similar methods we used,
this may not be the case. Additionally, the 30% thresh-
old is based on the assumption that the precision of the
reference technique is around 15%, while it may be
lower for TPTD [33]. Consequently, if the percentage
error for CO, GEDV, and EVLW would be close to 30%,
the two measurements might actually not have been
considered interchangeable. With a percentage error
substantially below 30%, as demonstrated in this study,
interchangeability can be safely assumed despite these
methodological issues. Another limitation is that in a
mixed population and without any predefined systematic
intervention, GEDV, EVLW and CO are not evenly
spread over the range of measurements, but are grouped
around their median. For the trending analysis, this
resulted in exclusion of roughly 50% of data points
using the traditional concordance approach, even with a
small exclusion zone of 10%. In contrast, the polar plot
concept recently proposed by Critchley et al. [19,20]
allowed the inclusion of all data points for trend analy-
sis. In order to entirely avoid the application of an
exclusion zone, the 30-degree radial limits were not
used for interpretation of the results. Another minor
limitation of the study is the high proportion of cardiac
surgical patients (56%), which might limit the extension
of the results beyond such a population. Finally, both
systems display continuous cardiac output, derived from
pulse contour analysis. These values are not part of this
analysis, but will have to be considered when comparing
the monitors in daily practice.
Conclusions
In a mixed ICU population, and in a wide range of clini-
cal situations, CO, GEDV and EVLW values assessed
with the new VolumeView™/EV1000™ system are
interchangeable with the current PiCCO™ method. The
study was not designed to demonstrate any superiority
of one algorithm over the other, but the higher precision
of GEDV measurements when the VolumeView™/
EV1000™ method was used suggests increased robust-
ness of the algorithm against thermal noise and
recirculation.
Key messages
• TPTD is a less invasive technique for CO measure-
ments; it does not depend on pulmonary arterial
catheterization. In addition to CO measurements,
TPTD additionally provides volumetric hemody-
namic parameters (GEDV and EVLW)
• Recently, a new TPTD system has been developed
that deploys a novel algorithm for GEDV and EVLW
• We compared measurements by that system to
those by a PiCCO2™ in 72 critically ill patients
Table 3 Agreement between CO, GEDV and EVLW
measurements by the VolumeView/EV1000™ and the
PiCCO2™ system.
r2 bias LOA % error
CO 0.981 0.2 ml/min 0.45 to 0.82 l/min 9.7%
GEDV 0.926 29.4 ml -130 to 189 ml 11.5%
EVLW 0.971 36.8 ml -40 to 113 ml 12.2%
CO, cardiac output; GEDV, global enddiastolic volume; EVLW, extravascular
lung water; LOA, limits of agreement.
Table 4 Agreement between trends in CO, GEDV and
EVLW measurements by the VolumeView/EV1000™ and
the PiCCO2™ system.
four quadrant plot polar plots
conctot conc10% concordance radial LOA
CO 87.6% 98.5% 100% 0.31 ml/minute
GEDV 81.5% 95.1% 99.7% 81 ml
EVLW 88.6% 97.7% 99.7% 40 ml
CO, cardiac output; GEDV, global enddiastolic volume; EVLW, extravascular
lung water; conctot, concordance rate including all data points; conc10%,
concordance rate using a 10% exclusion zone; LOA, limits of agreement.
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• The measurements by both systems agree closely,
as well for absolute measures (bias, percentage error)
as for measurements of change (concordance)
• For GEDV, the VolumeView Method had a higher
precision
Additional material
Additional file 1: Details of conversion of EVLW formulas. A step-by-
step conversion to demonstrate strict mathematical conformity of the
formulas used to calculate EVLW by the two devices (PiCCO2™™ and
Volume View™™).
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